vs
LANTRONIX INC(LTRX)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是LANTRONIX INC的1.2倍($35.5M vs $29.8M),LANTRONIX INC净利率更高(-4.5% vs -304.2%,领先299.8%),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs -4.5%),LANTRONIX INC自由现金流更多($2.1M vs $-47.3M),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs -15.0%)
Lantronix Inc是全球物联网安全连接与边缘计算解决方案提供商,面向工业、医疗、零售、交通、智慧城市等领域客户,供应专用硬件、SaaS平台与嵌入式软件,支持可靠的远程设备管理。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
LTRX vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.2倍
$29.8M
营收增速更快
RXRX
高出686.2%
-4.5%
净利率更高
LTRX
高出299.8%
-304.2%
自由现金流更多
LTRX
多$49.4M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-15.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $29.8M | $35.5M |
| 净利润 | $-1.3M | $-108.1M |
| 毛利率 | 43.6% | 59.8% |
| 营业利润率 | -3.6% | -304.8% |
| 净利率 | -4.5% | -304.2% |
| 营收同比 | -4.5% | 681.7% |
| 净利润同比 | 43.9% | 39.6% |
| 每股收益(稀释后) | $-0.03 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LTRX
RXRX
| Q4 25 | $29.8M | $35.5M | ||
| Q3 25 | $29.8M | $5.2M | ||
| Q2 25 | $28.8M | $19.2M | ||
| Q1 25 | $28.5M | $14.7M | ||
| Q4 24 | $31.2M | $4.5M | ||
| Q3 24 | $34.4M | $26.1M | ||
| Q2 24 | $49.1M | $14.4M | ||
| Q1 24 | $41.2M | $13.8M |
净利润
LTRX
RXRX
| Q4 25 | $-1.3M | $-108.1M | ||
| Q3 25 | $-1.4M | $-162.3M | ||
| Q2 25 | $-2.6M | $-171.9M | ||
| Q1 25 | $-3.9M | $-202.5M | ||
| Q4 24 | $-2.4M | $-178.9M | ||
| Q3 24 | $-2.5M | $-95.8M | ||
| Q2 24 | $386.0K | $-97.5M | ||
| Q1 24 | $-423.0K | $-91.4M |
毛利率
LTRX
RXRX
| Q4 25 | 43.6% | 59.8% | ||
| Q3 25 | 44.8% | -183.8% | ||
| Q2 25 | 40.0% | -4.9% | ||
| Q1 25 | 43.5% | -48.0% | ||
| Q4 24 | 42.6% | -181.4% | ||
| Q3 24 | 42.1% | 53.7% | ||
| Q2 24 | 38.1% | 36.2% | ||
| Q1 24 | 40.1% | 19.1% |
营业利润率
LTRX
RXRX
| Q4 25 | -3.6% | -304.8% | ||
| Q3 25 | -5.1% | -3327.6% | ||
| Q2 25 | -10.9% | -916.8% | ||
| Q1 25 | -12.6% | -1297.9% | ||
| Q4 24 | -6.9% | -4042.4% | ||
| Q3 24 | -6.2% | -377.1% | ||
| Q2 24 | 1.2% | -697.4% | ||
| Q1 24 | -0.2% | -698.4% |
净利率
LTRX
RXRX
| Q4 25 | -4.5% | -304.2% | ||
| Q3 25 | -4.7% | -3135.3% | ||
| Q2 25 | -9.1% | -894.2% | ||
| Q1 25 | -13.6% | -1373.3% | ||
| Q4 24 | -7.6% | -3935.5% | ||
| Q3 24 | -7.3% | -367.5% | ||
| Q2 24 | 0.8% | -676.6% | ||
| Q1 24 | -1.0% | -662.4% |
每股收益(稀释后)
LTRX
RXRX
| Q4 25 | $-0.03 | $-0.17 | ||
| Q3 25 | $-0.04 | $-0.36 | ||
| Q2 25 | $-0.06 | $-0.41 | ||
| Q1 25 | $-0.10 | $-0.50 | ||
| Q4 24 | $-0.06 | $-0.56 | ||
| Q3 24 | $-0.07 | $-0.34 | ||
| Q2 24 | $0.01 | $-0.40 | ||
| Q1 24 | $-0.01 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $23.0M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $74.4M | $1.1B |
| 总资产 | $121.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
LTRX
RXRX
| Q4 25 | $23.0M | $743.3M | ||
| Q3 25 | $22.2M | $659.8M | ||
| Q2 25 | $20.1M | $525.1M | ||
| Q1 25 | $20.0M | $500.5M | ||
| Q4 24 | $19.2M | $594.4M | ||
| Q3 24 | $26.4M | $427.6M | ||
| Q2 24 | $26.2M | $474.3M | ||
| Q1 24 | $24.6M | $296.3M |
总债务
LTRX
RXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益
LTRX
RXRX
| Q4 25 | $74.4M | $1.1B | ||
| Q3 25 | $74.5M | $1.0B | ||
| Q2 25 | $74.4M | $919.1M | ||
| Q1 25 | $75.5M | $933.9M | ||
| Q4 24 | $77.9M | $1.0B | ||
| Q3 24 | $78.9M | $524.6M | ||
| Q2 24 | $81.4M | $584.4M | ||
| Q1 24 | $78.1M | $401.2M |
总资产
LTRX
RXRX
| Q4 25 | $121.7M | $1.5B | ||
| Q3 25 | $119.6M | $1.4B | ||
| Q2 25 | $123.7M | $1.3B | ||
| Q1 25 | $124.2M | $1.3B | ||
| Q4 24 | $134.2M | $1.4B | ||
| Q3 24 | $137.9M | $726.5M | ||
| Q2 24 | $136.2M | $775.9M | ||
| Q1 24 | $147.4M | $557.8M |
负债/权益比
LTRX
RXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $2.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $2.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | 7.0% | -133.1% |
| 资本支出强度资本支出/营收 | 0.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $9.6M | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
LTRX
RXRX
| Q4 25 | $2.2M | $-46.1M | ||
| Q3 25 | $3.6M | $-117.4M | ||
| Q2 25 | $1.1M | $-76.4M | ||
| Q1 25 | $3.2M | $-132.0M | ||
| Q4 24 | $340.0K | $-115.4M | ||
| Q3 24 | $2.7M | $-59.2M | ||
| Q2 24 | $2.3M | $-82.2M | ||
| Q1 24 | $3.6M | $-102.3M |
自由现金流
LTRX
RXRX
| Q4 25 | $2.1M | $-47.3M | ||
| Q3 25 | $3.5M | $-117.6M | ||
| Q2 25 | $909.0K | $-79.6M | ||
| Q1 25 | $3.1M | $-133.8M | ||
| Q4 24 | $256.0K | $-116.7M | ||
| Q3 24 | $2.5M | $-63.8M | ||
| Q2 24 | $2.1M | $-83.4M | ||
| Q1 24 | $3.5M | $-109.0M |
自由现金流率
LTRX
RXRX
| Q4 25 | 7.0% | -133.1% | ||
| Q3 25 | 11.9% | -2272.5% | ||
| Q2 25 | 3.2% | -413.9% | ||
| Q1 25 | 10.9% | -907.4% | ||
| Q4 24 | 0.8% | -2567.7% | ||
| Q3 24 | 7.3% | -244.6% | ||
| Q2 24 | 4.3% | -578.5% | ||
| Q1 24 | 8.4% | -789.9% |
资本支出强度
LTRX
RXRX
| Q4 25 | 0.3% | 3.5% | ||
| Q3 25 | 0.2% | 4.7% | ||
| Q2 25 | 0.5% | 16.4% | ||
| Q1 25 | 0.4% | 12.4% | ||
| Q4 24 | 0.3% | 28.6% | ||
| Q3 24 | 0.5% | 17.5% | ||
| Q2 24 | 0.3% | 8.2% | ||
| Q1 24 | 0.3% | 48.2% |
现金转化率
LTRX
RXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.89× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LTRX
| Embedded Io T Solutions | $13.9M | 47% |
| Io T System Solutions | $13.3M | 45% |
| Software And Services | $2.6M | 9% |
RXRX
暂无分部数据